Immediate Impact
5 standout
Citing Papers
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients
2023 Standout
Vaccines and therapeutics for immunocompromised patients with COVID-19
2023 Standout
Works of Tara Lancaster being referenced
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tara Lancaster | 18 | 7 | 25 | 59 | 5 | 102 | |
| Becky Batchelor | 10 | 4 | 12 | 169 | 5 | 182 | |
| Kirsten Littlefield | 16 | 31 | 102 | 8 | 131 | ||
| Myriam Weber | 8 | 4 | 12 | 66 | 4 | 109 | |
| Ilaria Rancan | 28 | 2 | 38 | 163 | 7 | 173 | |
| Rodrigo Sánchez-Tarjuelo | 50 | 11 | 79 | 44 | 6 | 202 | |
| Jaiveer Singh | 33 | 5 | 28 | 83 | 9 | 183 | |
| Elisabeth Puchhammer | 14 | 2 | 27 | 25 | 6 | 177 | |
| Stacey McIntyre | 10 | 13 | 34 | 149 | 3 | 173 | |
| Hassan Tarhini | 21 | 12 | 14 | 130 | 8 | 184 | |
| Khalid S. Al-Khairy | 11 | 6 | 9 | 144 | 8 | 190 |
All Works
Login with ORCID to disown or claim papers
Loading papers...